person
as of 2026-07-01Robert Risinger, MD
at a glance
Roles: Study Chair, Study Director
KOL signal score 0
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Alkermes, Inc.
Roles
Study Chair, Study Director
KOL signal
0
Publications
0 (0 high-value)
Trial investigator
no
Trials led
5
An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
NCT01895452Phase 3Completed
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
NCT04268303Phase 3Completed
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
NCT05025605Phase 1Recruiting
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
NCT06041646Phase 4Completed
A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder
NCT02636842Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR
STUDY_CHAIR